MedTrace Logo

Attaining and Maintaining Wellness in Obsessive-compulsive Disorder

NCT01686087 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2019-03-13

No results posted yet for this study

Summary

The goal of this study is to understand whether patients with obsessive-compulsive disorder (OCD) on serotonin reuptake inhibitors (SRIs) who receive a type of Cognitive-behavioral therapy called Exposure and Ritual Prevention (EX/RP) can discontinue their medication if they first do well with EX/RP.

Conditions

  • Obsessive Compulsive Disorder

Interventions

BEHAVIORAL

Monthly Booster Sessions of EX/RP

45 minute EXRP booster sessions each month

PROCEDURE

Visits with MD and independent evaluators

All patients will be followed carefully and evaluated by their study doctor and an independent evaluator to assess their symptoms.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • New York State Psychiatric Institute

    lead OTHER

Principal Investigators

  • Helen B Simpson, MD PhD · NY State Psychiatric Institute at Columbia University

  • Edna Foa, PhD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2018-06-30
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01686087 on ClinicalTrials.gov